Haisco’s wholly-owned subsidiary Sichuan Haisco’s HSK3486 injection received the acceptance notice and the “drug clinical trial approval notice”_stock information_market_中金在线

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Read the original article: Caishen.Co